Quick Overview: The MindMed Chronicles A Conversation With Jake Freeman of Freeman Capital Psychedelic Invest In this video host Adam Tubero shares his thoughts regarding everything In this two-part interview Adam sits down with Dr. Scott Freeman Former CMO of Savant and Mind Medicine. We get into Scott's ...

The Mindmed Chronicles A Conversation - Detailed Overview & Context

The MindMed Chronicles A Conversation With Jake Freeman of Freeman Capital Psychedelic Invest In this video host Adam Tubero shares his thoughts regarding everything In this two-part interview Adam sits down with Dr. Scott Freeman Former CMO of Savant and Mind Medicine. We get into Scott's ... Optimized MDMA dosing, psychedelic precision medicine, LSD neutralizing ... The landscape of psychiatry is changing fast. Circa 2020, Kevin O'Leary was all about Mind Medicine (MNMD) — was a different ticker symbol at the time, and it wasn't yet on ... Host Adam Tubero discusses the latest events and happenings surrounding the hottest and most talked about psychedelics ...

In this week's episode of Weekly Extractions Adam talks about some of the highlights coming out of the psychedelic sector this ... In today's episode, James from PSYCBiz interviews Robert Barrow, CEO of With heavy improvisation influence, this performative piece illustrates a What if the exhaustion you feel isn't coming from how much you're carrying… but from the story you've been carrying about ...

Photo Gallery

The MindMed Chronicles | A Conversation With Robert Barrow CEO Of MindMed | Psychedelic Invest
The MindMed Chronicles | A Conversation With Jake Freeman of Freeman Capital | Psychedelic Invest
The MindMed Chronicles | A Conversation With Jake Freeman Part 2 | Psychedelic Invest
The MindMed Chronicles | Sharing My Perspective Around Everything MindMed | Psychedelic Invest
The MindMed Chronicles | Mindmed Shelf Offering - 9/27/2022 | Psychedelic Invest
The MindMed Chronicles | Live Q & A With Jake Freeman | Psychedelic Invest
Psychedelic Invest | The Freeman Chronicles Part 1 of 2 | An Interview with the former CMO of $MNMD
MindMed CEO Rob Barrow at Web Summit 2021: Therapy 2.0 - The next step in brain health
Why isn’t Kevin O’Leary talking about Mind Med (MNMD) any more?
Weekly Extractions | MindMed x Freeman Capital Management | Psychedelic Invest
PRO: Weekly Extractions | $DRUG, Mydecine, Jake Freeman x MindMed | Psychedelic Invest
MindMed CEO AMA: 18-MC Patent, Digital Tech, LSD Trials and More! (MNMD / MMED)
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored